Matthew Winton, Chief Commercial and Business at CervoMed Inc. (CRVO), bought 5,000 shares at $7.95 ($41K) on 2025-11-18, disclosed to the SEC on 2025-11-19.
Open-market purchase of $41k CRVO by Chief Commercial and Business. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.43 | 3,500 | $30K | 71.2% |
| 2 | $7.95 | 1,500 | $12K | 28.8% |
| Total | $8.29 avg | 5,000 | $41K | 100% |